These included Basal/Erbb2 Breast Cancer and Ovarian Cancer, Transcription/Translation and Mammary Stem Cell pathways that were induced, and Luminal Breast Cancer, Histone Methylation, Mitochondria and other metabolic as well as Cancer Associated pathways that were repressed (Supplemental Table 1). This evidence concerns the gene ERBB2 and ovarian carcinoma.